Gilead Sciences will ⁠buy privately held biotech firm Ouro Medicines in ‌a ⁠deal worth up to $2.18 ⁠billion

www.reuters.com

Gilead Sciences will ⁠buy privately held biotech firm Ouro Medicines in ‌a ⁠deal worth up to $2.18 ⁠billion

www.reuters.com

InnerworldM to

Mergers and Acquisitions (M&A)English · 1 day ago

reuters.com

www.reuters.com

You must log in or # to comment.

Chat

Mergers and Acquisitions (M&A)

Mergers_Acquisitions

Create a post

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: [email protected]

Transactions in which the ownership of companies, other business organizations, or their assets or operating units have been transferred or consolidated.

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

5 users / day
8 users / week
24 users / month
81 users / 6 months
15 local subscribers
17 subscribers
222 Posts
12 Comments
Modlog

mods:
Innerworld

Gilead ​Sciences will ⁠buy ​privately ​held biotech firm ​Ouro ​Medicines in ‌a ⁠deal worth ​up ​to $2.18 ⁠billion

Gilead ​Sciences will ⁠buy ​privately ​held biotech firm ​Ouro ​Medicines in ‌a ⁠deal worth ​up ​to $2.18 ⁠billion

reuters.com

Gilead Sciences will ⁠buy privately held biotech firm Ouro Medicines in ‌a ⁠deal worth up to $2.18 ⁠billion

Gilead Sciences will ⁠buy privately held biotech firm Ouro Medicines in ‌a ⁠deal worth up to $2.18 ⁠billion